HROW Q1 2019 Earnings — Harrow Health, Inc. Revenue & Financial Results | Market Cap Arena

HROWHarrow Health, Inc.

$1B

Q1 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$12M+38.6% YoY

Gross Profit

$8M68.3% margin

Operating Income

-$556,000-4.5% margin

Net Income

$11M92.4% margin

EPS (Diluted)

$0.43

QoQ Revenue Growth

+8.0%

Cash Flow

Operating Cash Flow

-$1M

Free Cash Flow

-$2M

Stock-Based Comp.

$788,000

Balance Sheet

Total Assets

$67M

Total Liabilities

$29M

Stockholders' Equity

$37M

Cash & Equivalents

$4M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$12M	$9M	+38.6%
Gross Profit	$8M	$5M	+75.1%
Operating Income	-$556,000	-$2M	+68.8%
Net Income	$11M	-$4M	+423.3%

Revenue Segments

License Revenues

$7,000100%